Results 161 to 170 of about 852,629 (213)

Być jak Modrzejewska!

open access: yesZarządzanie w Kulturze
Aleksandra Kuczara
doaj   +1 more source

An Update on JAK Inhibitors

Current Medicinal Chemistry, 2019
Janus kinases (JAKs) are a family of non-receptor tyrosine kinases, composed by four members, JAK1, JAK2, JAK3 and TYK2. JAKs are involved in different inflammatory and autoimmune diseases, as well as in malignancies, through the activation of the JAK/STAT signalling pathway.
Musumeci, Francesca   +7 more
openaire   +3 more sources

The Jak-STAT pathway

Molecular Immunology, 2000
A variety of important cellular functions are regulated by cytokines. The Jak-STAT pathway is one of the important signaling pathways downstream of cytokine receptors. Following binding of a ligand to its cognate receptor, receptor-associated Jaks are activated.
K, Imada, W J, Leonard
openaire   +2 more sources

A JAK-in-the-cell cycle

Blood, 2012
In this issue of Blood, Gautier and colleagues describe a novel signaling pathway in which deregulated JAK2 activity augments expression of a key regulator of the cell cycle, the CDC25A phosphatase, via a translational mechanism.
openaire   +3 more sources

Selective JAK Inhibitors

Future Medicinal Chemistry, 2014
Consisting of four members, JAK1, JAK2, JAK3 and TYK2, the JAK kinases have emerged as important targets for proliferative and immune-inflammatory disorders. Recent progress in the discovery of selective inhibitors has been significant, with selective compounds now reported for each isoform.
Brian W, Dymock   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy